Cargando…
Editorial: Translation of genetically engineered T cells in cancer immunotherapy
Autores principales: | Voss, Ralf-Holger, Echchannaoui, Hakim, Huang, He, Xue, Shao-An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513460/ https://www.ncbi.nlm.nih.gov/pubmed/37744369 http://dx.doi.org/10.3389/fimmu.2023.1278677 |
Ejemplares similares
-
Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022) -
Editorial: Post-translational modifications of proteins in cancer immunity and immunotherapy
por: Dai, Xiangpeng, et al.
Publicado: (2022) -
Editorial: Translational phenomics and its applications in immunotherapy
por: Fang, Hai, et al.
Publicado: (2023) -
An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells
por: Knies, Diana, et al.
Publicado: (2016) -
Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)